Colon Cancer Reversed by Phyto-Nutritional Therapy: A Case Study
DOI:
https://doi.org/10.6000/1927-3037.2013.02.03.4Keywords:
Colon cancer, metabolic disorder, complementary medicine, phyto-nutritional therapy, apoptosisAbstract
Colorectal cancer is the second most common cancer in Malaysia and up to 80% of its patients seek complementary therapies. Globally, up to 95% of cancer patient use adjunct therapies to reduce chemotherapy-induced side-effects. Morgan et al. (2004) had showed that conventional treatment for colon cancer produced minimal results. The vast majority of cancer survivors admitted to using dietary supplements and herbs after their cancer diagnosis. Current treatment seems to pay more attention to cancer as a disease rather than meeting the physiological needs of the patient. Nutritional therapy should be individually tailored since dietary deficiency is multifactorial and the tumor burden for each patient is different. Cancer is a metabolic disorder and colon cancer is strongly associated with advancing age, dietary and lifestyle habits. Up to 90% of all cancers might be prevented with proper nutrition since one-third of overall cancer deaths are linked to malnutrition. This case study shows how a late stage colon adenocarcinoma might be completely reversed by evidence-based phyto-nutritional therapy combined with some lifestyle modifications. The cancer apoptotic properties of this natural protocol warrant further investigation involving a higher number of patients with similar conditions.
References
Ravasco P, Monteiro Grillo I, Marques Vidal P, Camilo M. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol 2003; 15: 443-50. http://dx.doi.org/10.1016/S0936-6555(03)00155-9
Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, et al. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007; 4(12): 325. http://dx.doi.org/10.1371/journal.pmed.0040325
Larsson S, and Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 2006; 119(11): 2657-64. http://dx.doi.org/10.1002/ijc.22170
Layton D, Bogen KT, Knize MG, Hatch FT, Johnson VM,
et al. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995; 16: 39-52. http://dx.doi.org/10.1093/carcin/16.1.39
Aune D Chan DS, Lau R, Vieira R, Greenwood DC, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011; 343. http://dx.doi.org/10.1136/bmj.d6617
Gionvannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiological literature. J Natl Cancer Inst 1999; 91: 317-31. http://dx.doi.org/10.1093/jnci/91.4.317
Franceschi S, Bidoli E, La Vecchia C, Talamini R, D’Avonzo B, et al. Tomatoes and risk of digestive-tract cancers. Int J Cancer 1994; 59: 181-4. http://dx.doi.org/10.1002/ijc.2910590207
Hall M, Chavarro JE, Le IM, Willett WC, Ma J. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2008; 17: 1136-43. http://dx.doi.org/10.1158/1055-9965.EPI-07-2803
U.S. Department of Agriculture, Agricultural Research Service. 2013. USDA National Nutrient Database for Standard Reference, Release 26. Nutrient Lists. http://ndb.nal.usda.gov/ndb/nutrients/report/nutrientsfrm?max=25&offset=0&totCount=0&nutrient1=31&nutrient2=&nutrient3=&subset=0&fg=&sort=c&measureby=g. Accessed: September 26, 2013.
Salonen J, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 1985; 290: 417-20.
Qi W, Weber CT, Wasland K, Savkovic SD. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 2011; 11: 219. http://dx.doi.org/10.1186/1471-2407-11-219
Gong Y, Shu XO, Li H, Chow WH, Cai H, et al. Prospective cohort study of soy food intake and colorectal cancer risk in women. Am J Clin Nutr 2009; 89(2): 577-83. http://dx.doi.org/10.3945/ajcn.2008.26742
Zhao C, Giusti MM, Malik M, Moyer MP, Maqunson BA. Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem 2004; 52(20); 6122-8. http://dx.doi.org/10.1021/jf049517a
Ko C, Shen SC, Lee TJ, Chen YC. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 2005; 4(2): 281-90.
Steinmetz KA, Kuchi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 1994; 139: 1-15.
Cohen M, Bhagavan HN. Ascorbic acid and gastrointestinal cancer. J Am Coll Nutr 1995; 14: 565-78.
Larsson S, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. JAMA 2005; 293(1): 86-9. http://dx.doi.org/10.1001/jama.293.1.86
Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006; 4(8): 1035-8. http://dx.doi.org/10.1016/j.cgh.2006.03.020
Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995; 55(2): 259-66.
Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008; 37: 2558-74. http://dx.doi.org/10.1039/b801558a
Raju J, Rao CV. Diosgenin, a steroid saponin constituent of yams and fenugreek: emerging evidence for applications in medicine. In: Iraj Rasooli, ed. Bioactive Compounds in Phytomedicine. Shanghai: InTech 2012; pp. 125-42.
Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 381. http://dx.doi.org/10.1038/18793
Anderson RE, Fisher LJ, Hara Y, Harris T, Mak WB, et al. Green tea catechins partially protect DNA from OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals. Carcinogenesis 2001; 22(8): 1189-93. http://dx.doi.org/10.1093/carcin/22.8.1189
Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 2000; 72: 1047-52.
Dorant E, van den Prandt PA, Goldbohm RA, Hermus RJ, Sturmans F. Garlic and its significance for the prevention of cancer in humans: a critical view. Br J Cancer 1993; 67: 424-9.
Tanaka S, Haruma K, Kunihiro M, Nagata S, Kitadai Y, et al. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J Med Sci 2004; 53: 39-45.
Watson A, Collins P. Colon cancer: a civilization disorder. Digestive Diseases 2011; 29 (2): 222-8. http://dx.doi.org/10.1159/000323926
Garcea G, Berry DP, Jones DH, Sing R, Dennison AR, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epid Biomarkers Prev 2005; 14(1): 120-5.
Aggarwal B, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A): 363-98.
Nagabhushan M, Bhide S. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992; 11(2): 192-8.
Sharma R, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41(13): 1955-68. http://dx.doi.org/10.1016/j.ejca.2005.05.009
Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4(6): 376-83.
Zeng L, Wu FE, Oberlies BH, McLaughlin JL, Sastrodihadjo S. Five new monotetrahydrofuran ring acetogenins from the leaves of Annon amuricata. J Nat Prod 1996; 59(11): 1035-42. http://dx.doi.org/10.1021/np960447e
Kim DH, Ma ES, Suk KD, Son JK, Lee JS, et al. Annomolin and annocherimolin, new cytotoxic annonaceous acetogenins from Annona cherimolia seeds. J Nat Prod 2001; 64(4): 502-6. http://dx.doi.org/10.1021/np000335u
Kim GS, Zeng L, Alali F, Rogers LL, Wu FE, et al. Two new mono-tetrahydrofuran ring acetogenins, annomuricin E and muricapentocin, from the leaves of Annona muricata. J Nat Prod 1998; 61(4): 432-6. http://dx.doi.org/10.1021/np970534m
Phillips-Howard P. Regulation of the quality and use of artemisinin and its derivatives. In: Artimisia. Wright CW ed. London: Taylor and Francis 2002.
Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The malarial artesunate is also active against cancer. Int J Oncol 2001; 18: 767-73.
Singh N, Lai, H. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res 2005; 25(6): 4325-31.
Kwon C. Phytochemical constituents of Artemisia stolonifera. Arch Pharm Res 2001; 24(4): 312-5. http://dx.doi.org/10.1007/BF02975098
Klayman D. Qinghaosu (Artemisinin): Antimalarial drug from China. Science 1985; 238: 1049.
Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Cur Drug Targets 2006; 7: 407-21. http://dx.doi.org/10.2174/138945006776359412
Willcox M. Artemesiaannua as a traditional herbal antimalarial. In: Willox M, Bodeker G, Rasoanaivo P. Eds.Traditional Medicinal Plants and Malaria. New York: CRC Press 2004; p. 46.
Schaller J. The use of the herb artemisinin for babesia, malaria and cancer. Florida: Hope Academic Press 2006.
Lai H, Narendra S. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. J Cancer Lett 1995; 91; 41-6. http://dx.doi.org/10.1016/0304-3835(94)03716-V
May W Jr, Cuatrecasas P. Transferrin receptor: its biological significance. J Membr Biol 1985; 88: 205-15.
Singh N, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001; 70: 49-56.
Bulter AR, Gilbert BC, Hulme P, Irvine LR, Renton L, et al. EPR evidence for the involvement of free radicals in the iron-catalysed decomposition of Qinghaosu (Artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides. Free Radic Res 1998; 28: 471-6. http://dx.doi.org/10.3109/10715769809066884
Moore JC, Lai H, Li JR, Ren RL, McDougall JA, et al. Oral administration of dihydro-artemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in rat. Cancer Lett 1995; 98: 83-7. http://dx.doi.org/10.1016/S0304-3835(06)80014-5
Anfosso L, Efferth T, Albini A, Pfeffer U. Microarray expression profiles of angiogenesis-related gene predict tumor cell response to artemisinins. J Pharmacogenomics 2006; 6: 269-78. http://dx.doi.org/10.1038/sj.tpj.6500371
Vanamala J, Reddivari L, Radhakrishnan S, Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 2010; 10: 238. http://dx.doi.org/10.1186/1471-2407-10-238
Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Du J, et al. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer 2009; 61(4): 544-53. http://dx.doi.org/10.1080/01635580902752262
Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 2003; 309(4): 1017-26. http://dx.doi.org/10.1016/j.bbrc.2003.08.105
Clark LC, Combs GR Jr, Turnbull BW, Slate EH, Chalker DK, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276: 1957-63. http://dx.doi.org/10.1001/jama.1996.03540240035027
National Research Council Staff. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy of Education 1989; pp. 376-9.
Schrauzer G. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 2003; 47: 73-112.
Tisdale M. Cancer cachexia. Anticancer Drugs 1993; 4(2): 115-25.
Mason J, Lavesque T. Folate: effects on carcinogenesis and the potential for cancer chemopreventon. Oncology 1996; 10: 1727-43.
Kim Y, Mason J. Folate, epithelial dysplasia, and colon cancer. Proc Assoc Am Physicians 1995; 107: 218-27.
Tseng M, Murray SC, Kupper LL, Sandler RS. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol 1996; 144: 1005-14.
Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: A randomized chemoprevention trial. World J Gastroenterol 2008; 14: 4492-8. http://dx.doi.org/10.3748/wjg.14.4492
Pence B. Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat Res 1993; 290: 87-95. http://dx.doi.org/10.1016/0027-5107(93)90036-F
Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, et al. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst 1995; 87: 1307-15. http://dx.doi.org/10.1093/jnci/87.17.1307
Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 1998; 280: 1074-9. http://dx.doi.org/10.1001/jama.280.12.1074
Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW,
et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999; 340: 101-7. http://dx.doi.org/10.1056/NEJM199901143400204
Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2008; CD003548. http://dx.doi.org/10.1002/14651858.CD003548.pub4
Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007; 99: 129-36.
Larsson SC, Orsini N, Wolk A. Diabetes Mellitus and risk of colorectal cancer: A Meta-Analysis. J Natl Cancer Inst 2005; 97(2): 1679-87. http://dx.doi.org/10.1093/jnci/dji375
Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141-7. http://dx.doi.org/10.1056/NEJM199407213310301
Macready N. Vitamins associated with lower colon-cancer risk. Lancet 1997; 350: 1452. http://dx.doi.org/10.1016/S0140-6736(05)64218-3
White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 769-74.
Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 1993; 53: 4230-7.
Martinez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996; 88(19): 1375-82. http://dx.doi.org/10.1093/jnci/88.19.1375
Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996; 143(9): 907-17.
McCullough ML, Robertson AS, Rodriquez C, Jacobs EJ, Chao A, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 2003; 14(1): 1-12.
Lieberman DA, Prindiville S, Weiss DG, Willet W, VA Cooperative Study Group 380. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290(22): 2959-67. http://dx.doi.org/10.1001/jama.290.22.2959
Benito E, Obrador A, Stiggelbout A, Bosch FX, Mulet M, et al. A population-based case-control study of colorectal cancer in Majorca, I: dietary factors. Int J Cancer 1990; 45(1): 69-76.
Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 238(10): 891-9. http://dx.doi.org/10.1056/NEJMoa021735
Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325(23): 1593-6. http://dx.doi.org/10.1056/NEJM199112053252301
Dube C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 46(5): 365-75. http://dx.doi.org/10.7326/0003-4819-146-5-200703060-00009
He J, Whelton PK, Vu B, Klaq MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280(22): 1930-5. http://dx.doi.org/10.1001/jama.280.22.1930
Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Engl J Med 2009; 361(25): 2449-60. http://dx.doi.org/10.1056/NEJM ra0804588
National Cancer Registry Report 2007. Malaysian Cancer Statistics: Data and Facts. Non-Communicable Disease Section. Malaysia: Ministry of Health 2011; p. 36.
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. Colorectal cancer. Lancet 2010; 375 (9719): 1030-47. http://dx.doi.org/10.1016/S0140-6736(10)60353-4
Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, et al. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004; 127(3): 777-91. http://dx.doi.org/10.1053/j.gastro.2004.06.049
Bian Y, Caldes T, Winnen J, Franken P, Vasen H, et al. TGFBR1/6A may contribute to hereditary colorectal cancer. J Clin Oncol 2005; 23(13): 3074-8. http://dx.doi.org/10.1200/JCO.2005.00.281
Astin M, Griffin T, Neal RD, Rose P, Hamilton Wl. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract 2011; 61(586): 231-43. http://dx.doi.org/10.3399/bjgp11X572427
Grant J. Proper use and recognized role of TPN in the cancer patient. Nutrition 1990; 6(4): 6s-7s.
National Cancer Institute. http://www.uicc.org/membership/ national-cancer-institute-usa. Accessed: July 20, 2013.
Jawad N, Direkze N, Leedham SJ. Inflammatory bowel disease and colon cancer. Recent results in cancer research. Fortschritte der Krebsforschung 2011; 185: 99-115. http://dx.doi.org/10.1007/978-3-642-03503-6_6
Larsson SC, Giovannucci E, Bergkvist L, Wolk A. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer 2005; 92(9): 1803-7.
Allen TD, Moore DR, Wang X, Casu V, May R, et al. Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression. J Med Microbiol 2008; 57: 1193-204. http://dx.doi.org/10.1099/jmm.0.47798-0
Garland C, Shekelle RB, Barrett-Connor E, Crique MH, Rossoff AH, et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; 1(8424): 307-9. http://dx.doi.org/10.1016/S0140-6736(85)91082-7
Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 2: 1176-8. http://dx.doi.org/10.1016/S0140-6736(89)91789-3
Garland C and Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9(3): 227-31. http://dx.doi.org/10.1093/ije/dyi229
Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.Cancer Epidemiol Biomarkers Prev 2001; 10(12): 1267-74.
Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003; 95(23): 1765-71. http://dx.doi.org/10.1093/jnci/djg110
Feskanich D, MaJ, Fuchs CS, Kirkner GJ, Hankinson SE, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13(9): 1502-8.
Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997; 8(4): 615-25. http://dx.doi.org/10.1023/A:1018450531136
Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10–17 years prior to diagnosis. Am J Epidemiol 1995; 142(6): 608-11.
Lipkin M and Newmark H. Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colon cancer. N Engl J Med 1985; 313: 1381-4. http://dx.doi.org/10.1056/NEJM198511283132203
Lamprecht S, Lipkin M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis 2002; 23(11): 1777-80. http://dx.doi.org/10.1093/carcin/23.11.1777
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 2004; 12(4): 246-52. http://dx.doi.org/10.1007/s00520-003-0568-z
Morgan G, Ward R, Barton M. The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies. Clin Oncol 2004; 16: 549-60. http://dx.doi.org/10.1016/j.clon.2004.06.007
Fisher D, Malpas P, Dominitz J, Cash B, Evas J, et al. Complications of colonoscopy. Gastrointestional Endoscopy 2011; 74(4): 745-52. http://dx.doi.org/10.1016/j.gie.2011.07.025
Winawer SJ, Zauber AG, Ho MN, O’Brian MJ, Gottlieb LS,
et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329(27): 1977-81. http://dx.doi.org/10.1056/NEJM199312303292701
Downloads
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
